1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Kowa Pharmaceuticals

Anonymous board for Kowa Pharmaceuticals


Sort By:
Title
Replies Views ↓
Last Message
  1. Anonymous
    Replies:
    45
    Views:
    17,153
  2. Anonymous
    Replies:
    52
    Views:
    15,499
  3. Anonymous
    Replies:
    47
    Views:
    11,388
  4. Anonymous
    Replies:
    29
    Views:
    11,222
  5. Anonymous
    Replies:
    104
    Views:
    10,776
  6. Anonymous
    Replies:
    15
    Views:
    9,324
  7. Anonymous
    Replies:
    12
    Views:
    8,869
  8. Anonymous
    Replies:
    22
    Views:
    8,297
  9. Anonymous
    Replies:
    7
    Views:
    7,476
  10. Anonymous
    Replies:
    11
    Views:
    6,963
  11. Anonymous
    Replies:
    13
    Views:
    6,891
  12. kjodienda
    Replies:
    25
    Views:
    6,690
  13. anonymous
    Replies:
    9
    Views:
    6,613
  14. Anonymous
    Replies:
    13
    Views:
    6,587
  15. anonymous
    Replies:
    15
    Views:
    6,396
  16. Anonymous
    Replies:
    10
    Views:
    6,124
  17. Anonymous
    Replies:
    15
    Views:
    5,971
  18. Anonymous
    Replies:
    30
    Views:
    5,805
  19. anonymous
    Replies:
    26
    Views:
    5,518
  20. Anonymous
    Replies:
    8
    Views:
    5,514

Thread Display Options

Loading...